GlassScriptPhysician profile
Ada Camejo Hanlon
NPI 1598766057
$1,233.74
in general payments reported to CMS, 2019-2025
19 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $75.59 · 2021: $366 · 2022: $162 · 2023: $66.99 · 2024: $201 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $446.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $188.83 | 2019-2025 | Bexsero, Rotarix |
| Merck Sharp & Dohme LLC | $152.06 | 2019-2025 | Gardasil 9, Vaxneuvance, Enflonsia |
| Cranial Technologies, INC | $151.25 | 2019-2024 | Doc Band |
| Tris Pharma INC | $97.17 | 2019-2021 | |
| Corium, LLC | $92.86 | 2021-2024 | Azstarys |
| Supernus Pharmaceuticals, INC. | $83.76 | 2021-2022 | |
| Sanofi Pasteur INC. | $66.50 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $57.27 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $57.24 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $47.49 | 2019-2021 | |
| Pfizer INC. | $44.30 | 2019-2024 | |
| Ironshore Pharmaceuticals INC. | $41.63 | 2019-2024 | |
| Soleno Therapeutics, INC. | $33.02 | 2025 | Vykat Xr |
| Adlon Therapeutics L.P. | $31.86 | 2021 | |
| Verrica Pharmaceuticals INC. | $20.52 | 2024 | Ycanth |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $20.16 | 2025 | Neffy |
| Seqirus USA INC | $19.36 | 2024 | Flucelvax |
| Dermira, INC. | $14.41 | 2020 | |
| Neos Therapeutics, LP | $14.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ada Hanlon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.